Biohaven (BHVN) Change in Accured Expenses (2021 - 2026)

Biohaven (BHVN) has 6 years of Change in Accured Expenses data on file, last reported at -$64.4 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Accured Expenses fell 2415.38% year-over-year to -$64.4 million; the trailing twelve-month figure through Mar 2026 stood at -$63.0 million (down 3880.55% YoY), and the FY2025 full-year result was $4.2 million, down 47.73% from the prior year.
• Change in Accured Expenses eased to -$64.4 million in Q1 2026, from -$12.8 million in the prior quarter.
• In the past five years, Change in Accured Expenses ranged from a high of $33.1 million in Q2 2022 to a low of -$64.4 million in Q1 2026.
• A 5-year average of -$3.1 million and a median of $2.8 million in 2025 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses surged 222.96% in 2025 and plunged 2415.38% in 2026, its largest moves.
• Tracing BHVN's Change in Accured Expenses over 5 years: stood at $18.7 million in 2022, then tumbled by 172.34% to -$13.5 million in 2023, then advanced by 6.61% to -$12.6 million in 2024, then decreased by 1.26% to -$12.8 million in 2025, then tumbled by 403.55% to -$64.4 million in 2026.
• Business Quant data shows BHVN's Change in Accured Expenses at -$64.4 million in Q1 2026, -$12.8 million in Q4 2025, and -$7.4 million in Q3 2025.